{"id":765444,"date":"2026-06-28T09:21:42","date_gmt":"2026-06-28T09:21:42","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/765444\/"},"modified":"2026-06-28T09:21:42","modified_gmt":"2026-06-28T09:21:42","slug":"novo-nordisk-a-s-nvo-primary-owner-to-open-obesity-drug-incubators-across-europe","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/765444\/","title":{"rendered":"Novo Nordisk A\/S (NVO) Primary Owner to Open Obesity Drug Incubators Across Europe"},"content":{"rendered":"\n<p class=\"text text-block paragraph text-justify neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Novo Nordisk A\/S (NYSE:NVO) is among the\u00a0<a href=\"https:\/\/www.insidermonkey.com\/blog\/12-best-ai-drug-discovery-stocks-hedge-funds-are-loading-up-on-1786015\/\" data-ylk=\"slk:Best%20Pharmaceutical%20Stocks;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkText&quot;:&quot;Best Pharmaceutical Stocks&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Best Pharmaceutical Stocks<\/a>.  <\/p>\n<p class=\"text text-block paragraph text-justify neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">On June 19, Novo Nordisk A\/S (NYSE:NVO)&#8217;s primary owner, the Novo Nordisk Foundation, reported that it is launching research incubators across Europe to speed up obesity and diabetes drug development. The foundation said it is funding a pan-European program targeting cardiometabolic diseases. It will commit up to DKK 450 million (EUR 60.2 million) over six years, opening its first lab in London this month, followed by sites in Italy and Germany.  <\/p>\n<p class=\"text text-block paragraph text-justify neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Novo Nordisk Foundation&#8217;s CEO Mads Krogsgaard Thomsen said the effort plans to convert &#8220;extraordinary science&#8221; into drug discovery projects, addressing a gap where academic breakthroughs fail to reach patients. Professor Graham Cooke of Imperial College London said many discoveries lack support to progress commercially and that London&#8217;s selection is a reflection of its strong ecosystem.  <\/p>\n<p>    <a href=\"https:\/\/s.yimg.com\/lo\/mysterio\/api\/F28AFAF51F597F8C2C0EE79CA040EEAF283F7566912DB38596123D60F28DF9A0\/subgraphmysterio\/resizefit_w960;quality_80;format_webp\/https:%2F%2Fmedia.zenfs.com%2Fen%2Finsidermonkey.com%2F5f39fa6d9fe58b75cf0609e8b49ba3a9\" target=\"_blank\" rel=\"noopener noreferrer nofollow\"><img loading=\"lazy\" decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/ywAAAAAAQABAAACAUwAOw==\" alt=\"Novo Nordisk A\/S (NVO) Primary Owner to Open Obesity Drug Incubators Across Europe\" height=\"640\" width=\"960\" class=\"yf-lglytj loader\"\/><\/a> Novo Nordisk A\/S (NVO) Primary Owner to Open Obesity Drug Incubators Across Europe           <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\"> Pixabay\/Public Domain  <\/p>\n<p class=\"text text-block paragraph text-justify neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">The foundation said the BioInnovation Institute will lead the initiative. Its CEO, Jens Nielsen, commented that its scale &#8220;supports research and innovation that can benefit patients and society.&#8221;  <\/p>\n<p class=\"text text-block paragraph text-justify neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Novo Nordisk A\/S (NYSE:NVO) is a global healthcare company. It works in the discovery, development, manufacturing, and marketing of pharmaceutical products. It functions through the Diabetes and Obesity Care and Rare Disease segments.  <\/p>\n<p class=\"text text-block paragraph text-justify neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">While we acknowledge the potential of NVO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you&#8217;re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the<a href=\"https:\/\/www.insidermonkey.com\/blog\/three-megatrends-one-overlooked-stock-massive-upside-1548959\/\" data-ylk=\"slk:;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkText&quot;:&quot;&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"fui-Link ___1q1shib f2hkw1w f3rmtva f1ewtqcl fyind8e f1k6fduh f1w7gpdv fk6fouc fjoy568 figsok6 f1s184ao f1mk8lai fnbmjn9 f1o700av f13mvf36 f1cmlufx f9n3di6 f1ids18y f1tx3yz7 f1deo86v f1eh06m1 f1iescvh fhgqx19 f1olyrje f1p93eir f1nev41a f1h8hb77 f1lqvz6u f10aw75t fsle3fq f17ae5zn\">\u00a0<\/a><a href=\"https:\/\/www.insidermonkey.com\/blog\/three-megatrends-one-overlooked-stock-massive-upside-1548959\/\" data-ylk=\"slk:best%20short-term%20AI%20stock;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkText&quot;:&quot;best short-term AI stock&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"fui-Link ___1q1shib f2hkw1w f3rmtva f1ewtqcl fyind8e f1k6fduh f1w7gpdv fk6fouc fjoy568 figsok6 f1s184ao f1mk8lai fnbmjn9 f1o700av f13mvf36 f1cmlufx f9n3di6 f1ids18y f1tx3yz7 f1deo86v f1eh06m1 f1iescvh fhgqx19 f1olyrje f1p93eir f1nev41a f1h8hb77 f1lqvz6u f10aw75t fsle3fq f17ae5zn\">best short-term AI stock<\/a>.  <\/p>\n<p class=\"text text-block paragraph text-justify neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">READ NEXT:\u00a0<a href=\"https:\/\/www.insidermonkey.com\/blog\/33-stocks-that-should-double-in-3-years-1709437\/\" data-ylk=\"slk:33%20Stocks%20That%20Should%20Double%20in%203%20Years;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkText&quot;:&quot;33 Stocks That Should Double in 3 Years&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"fui-Link ___1q1shib f2hkw1w f3rmtva f1ewtqcl fyind8e f1k6fduh f1w7gpdv fk6fouc fjoy568 figsok6 f1s184ao f1mk8lai fnbmjn9 f1o700av f13mvf36 f1cmlufx f9n3di6 f1ids18y f1tx3yz7 f1deo86v f1eh06m1 f1iescvh fhgqx19 f1olyrje f1p93eir f1nev41a f1h8hb77 f1lqvz6u f10aw75t fsle3fq f17ae5zn\">33 Stocks That Should Double in 3 Years<\/a> and <a href=\"https:\/\/www.insidermonkey.com\/blog\/cathie-wood-2026-portfolio-10-best-stocks-to-buy-1716175\/\" data-ylk=\"slk:Cathie%20Wood%202026%20Portfolio%3A%2010%20Best%20Stocks%20to%20Buy;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkText&quot;:&quot;Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"row-title\">Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy<\/a>.\u00a0  <\/p>\n<p class=\"text text-block paragraph text-justify neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Disclosure: None. <a href=\"https:\/\/news.google.com\/publications\/CAAqLQgKIidDQklTRndnTWFoTUtFV2x1YzJsa1pYSnRiMjVyWlhrdVkyOXRLQUFQAQ?hl=en-US&amp;gl=US&amp;ceid=US%3Aen\" data-ylk=\"slk:Follow%20Insider%20Monkey%20on%20Google%20News;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkText&quot;:&quot;Follow Insider Monkey on Google News&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"fui-Link ___1q1shib f2hkw1w f3rmtva f1ewtqcl fyind8e f1k6fduh f1w7gpdv fk6fouc fjoy568 figsok6 f1s184ao f1mk8lai fnbmjn9 f1o700av f13mvf36 f1cmlufx f9n3di6 f1ids18y f1tx3yz7 f1deo86v f1eh06m1 f1iescvh fhgqx19 f1olyrje f1p93eir f1nev41a f1h8hb77 f1lqvz6u f10aw75t fsle3fq f17ae5zn\">Follow Insider Monkey on Google News<\/a>.  <\/p>\n","protected":false},"excerpt":{"rendered":"Novo Nordisk A\/S (NYSE:NVO) is among the\u00a0Best Pharmaceutical Stocks. On June 19, Novo Nordisk A\/S (NYSE:NVO)&#8217;s primary owner,&hellip;\n","protected":false},"author":2,"featured_media":765445,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[64,63,364737,5819,137,500,67030,364736,5889,6691,245522],"class_list":["post-765444","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-au","tag-australia","tag-best-pharmaceutical-stocks","tag-graham-cooke","tag-health","tag-healthcare","tag-imperial-college-london","tag-mads-krogsgaard-thomsen","tag-novo-nordisk","tag-novo-nordisk-foundation","tag-obesity-and-diabetes"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/765444","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=765444"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/765444\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/765445"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=765444"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=765444"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=765444"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}